Training resident physicians in research on immune-mediated and infectious diseases
Official title: The Ohio State University Research in Residency Physician Scientist Initiative
Funded at Ohio State University · NIH-10810244 · Data updated 2026-11-12
This study is for resident doctors who want to learn more about treating immune-related and infectious diseases by working with experienced researchers and getting hands-on training in research methods.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project start | July 1, 2024 |
| Project end | June 30, 2029 |
| Funding year | 2024 |
| Award (this year) | $412,613 |
| NIH project number | 1R38AI174264-01A1 |
| Project ID | NIH-10810244 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this program are resident physicians in training who are interested in pursuing research in the fields of immunology and infectious diseases.
✕Less likely to help
Patients who are not involved in medical training or research, such as those seeking direct clinical care without an interest in research, may not benefit from this initiative.
What this research studies
The Ohio State University R38 StARR Program offers a two-year training opportunity for resident physicians to engage in research focused on immune-mediated diseases and infectious diseases. This program emphasizes a collaborative and multidisciplinary approach, allowing residents to work alongside experienced physician scientists and mentors. Participants will gain hands-on experience in research methodologies and contribute to advancing knowledge in immunotherapeutics and disease management. The program also fosters networking and peer mentoring among trainees at various stages of their medical careers.
Why it matters
Potential benefit: If successful, this research initiative could enhance the training of future physician scientists, leading to improved treatments and understanding of immune-mediated and infectious diseases.
How similar studies have gone: Similar programs at other institutions have successfully trained physician scientists, indicating a strong potential for success in this initiative.
Where this research is happening
-
Ohio State University
Columbus, United States Active
Researchers
- Principal investigator: Bumgardner, Ginny L — Ohio State University
- Study coordinator: Bumgardner, Ginny L
Related research
Other NIH-funded projects on the same topics.
-
Understanding how trinucleotide repeat expansions cause disease
A research project at Ohio State University is exploring how tiny DNA repeats become unstable and drive neurological and muscular diseases, with potential implications for future therapies.
-
Pediatric Prehospital Airway Resuscitation for Critically Ill Children
This grant tests the best way for paramedics to manage breathing tubes and other airways in seriously ill children before they reach the hospital.
-
From Social Breakups to Brain Changes in Alzheimer’s and Related Dementias
This grant explores how losing social connections may trigger brain changes and inflammation linked to Alzheimer’s disease and related dementias.
-
Understanding why patients with blood cancers start and stick with oral cancer medicines
A study to learn what helps or hinders Black patients with blood cancers in starting and continuing their prescribed oral cancer medicines.
-
How sex and hormones affect alcohol's impact on sleep in adults
This study tests how sex and hormone changes influence how alcohol disrupts sleep in healthy adults, with a focus on women aged 21-45.
-
Natural products to block IL-8 signaling and prevent Barrett's Esophagus from turning into esophageal cancer
A搜索-friendly plan to use safe natural compounds to interrupt a key inflammatory signal (IL-8) and stop Barrett’s esophagus from turning into esophageal cancer in people with GERD.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.